William Donovan receives ACR Thorwarth Award

Kamala Harris widely expected to continue Cancer Moonshot; Conservatives present their vision in Project 2025

What will happen to biomedical research and health care in the aftermath of the 2024 election? The differences in outcomes couldn’t be more stark.

July 26, 2024

Vol.50 No.30

By McKenzie Prillaman

In Brief

Monica Bertagnolli and Brett Guthrie named Friends 2024 Cancer Leadership Award recipients

Monica BertagnolliBrett GuthrieNIH Director Monica Bertagnolli and Rep. for Kentucky’s 2nd congressional district, Brett Guthrie were named recipients of Friends of Cancer Research 2024 Cancer Leadership Award.

July 19, 2024

Vol.50 No.29

Drugs & Targets

FDA grants Fast Track designation to 225Ac-FL-020 radiopharmaceutical for mCRPC

FDA granted Fast Track designation for Ac-FL-020, a radiopharmaceutical which targets prostate-specific membrane antigen for the treatment of metastatic castration-resistant prostate cancer.xxx:more

July 12, 2024

Vol.50 No.28

In Brief

Fred Hutch announces eight recipients of 2024 Eddie Méndez Scholar Award

Fred Hutch Cancer Center announced the recipients of the 2024 Dr. Eddie Méndez Scholar Award, which recognizes early-career scientists from underrepresented backgrounds who are studying cancer, infectious diseases, and basic sciences.

June 21, 2024

Vol.50 No.25

In Brief

NCCN patient resources receive Hemes Creative Award, Communicator Award, Viddy Award

The National Comprehensive Cancer Network announced recognitions for the award-winning library of NCCN Guidelines for Patients and NCCN Patient Webinars.

June 21, 2024

Vol.50 No.25

Editorial

The Cancer Letter receives six journalism, design awards

The Cancer Letter staff were finalists for six 2024 Dateline Awards from the Washington, DC, Chapter of the Society of Professional Journalists—three for journalism, and three for design—and won first place for two.

June 14, 2024

Vol.50 No.24

By Katie Goldberg